
Company profile
Ticker
FMS, FMCQF
Exchange
Website
CEO
Rice Powell
Employees
Location
Fiscal year end
Industry (SIC)
SEC CIK
FMS stock data
News

Stocks That Hit 52-Week Lows On Wednesday
3 Aug 22
Stocks That Hit 52-Week Lows On Monday
1 Aug 22
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
29 Jul 22
Why Did Fresenius Medical Care Shares Plunge To 52-Week Low
28 Jul 22
12 Health Care Stocks Moving In Thursday's Intraday Session
28 Jul 22
Press releases
CytoSorb® Becomes a Featured Blood Purification Therapy on Fresenius Medical Care Critical Care Platforms
2 Aug 22
Fresenius Medical Care North America Introduces First Single-Use Integrated Bloodline to Support Fluid Management in Dialysis
27 Jul 22
Highmark Interactive Inc. Announces Collaboration with Renal Research Institute to Identify Potential Biomarkers of Brain Injury in Hemodialysis Patients
20 Jun 22
Analyst ratings and price targets
Calendar
22 Feb 22
12 Aug 22
31 Dec 22
Financial summary
Quarter (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q1 2022
5.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 176 |
Opened positions | 24 |
Closed positions | 22 |
Increased positions | 63 |
Reduced positions | 39 |
13F shares | Current |
---|---|
Total value | 2.12B |
Total shares | 30.58M |
Total puts | 11.9K |
Total calls | 70K |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
PZN Pzena Investment Management | 11.58M | $389.94M |
Fiduciary Management | 6.54M | $220.32M |
First Trust Advisors | 1.87M | $63.1M |
Cambiar Investors | 1.36M | $45.94M |
Dodge & Cox | 1.28M | $42.96M |
BAC Bank Of America | 1.08M | $36.5M |
Tweedy, Browne | 1.03M | $34.59M |
C Citigroup | 662.66K | $22.32M |
Parametric Portfolio Associates | 483.4K | $16.28M |
IVZ Invesco | 456.01K | $15.36M |
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absorption, alienate, Alpha, anesthesia, antibody, anticoagulation, ANVISA, appetite, ARUG, awaiting, BBB, binomial, Biology, Bluetooth, BMW, Brazilian, Brigham, BS, built, catheterization, cell, cessation, Chinese, climate, cloud, column, conservative, Cox, CRRT, curative, database, decode, DeepHealth, Deerfield, desist, difelikefalin, Dodge, ECMO, editing, effectually, EHR, embodying, ESG, ESKD, Evanston, exemplified, expiry, explanation, feedback, fit, footnote, forefront, forfeiture, Francisco, freight, Frenova, FTE, Gdansk, gene, genome, genomic, Gesetz, gregory, guiding, halt, hardship, HemoflowTM, hydrolayer, hygiene, IBOR, IC, ID, IGBCE, Imaging, immune, Inline, insider, interbank, interval, Ireland, islet, JSC, judged, Kawasumi, KDE, Kellogg, kit, Lending, lifted, lightweight, logic, Lundberg, MBA, MBBP, MDSAP, MedTech, Memo, Minnesota, MUFG, multicurrency, multifiltratepro, MyTraining, Nephew, nonrecurring, Northwestern, Organisation, overarching, overcome, overspend, PAYGO, permeability, Pillar, pivotal, plausibility, preclinical, proliferation, PureFlowSL, QR, reality, reallocation, regime, reinforce, reopened, repeat, repository, Rescue, resistance, resume, sample, sampling, San, schematic, shadow, simulation, Smith, socioeconomic, sorensen, Spring, stratifying, surprise, surveillance, Swingline, telehealth, temporal, theHub, thing, timeframe, trainer, turnover, umbrella, Umsetzung, unanticipated, unavoidable, undiscounted, undrawn, unvaccinated, upheld, upholding, usable, vendor, VersiPD, viral, VR, Warsaw, weighing, workplace, Xenotransplant, zur, zweiten
Removed:
AIC, AIMD, AKI, AMP, Amsterdam, annum, appendix, Arizona, averaged, bachelor, Ben, Berlin, binominal, Biotronik, Blue, Bosch, BPCI, cardiogenic, Carolina, Charit, Chase, clean, client, closest, collaborating, combinational, Commerzbank, concrete, consequentially, contact, contradictory, converting, costly, debit, delivered, Den, disbursed, dismantle, disregard, Distinction, distributer, Duesseldorf, EPS, Ergo, existed, exploring, Fargo, feature, Gallian, greatly, Hemoflow, Hong, hospitalist, hyperinflation, idea, IFRIC, implantable, Indiana, instruction, intensive, intensivist, intervention, Jersey, JPMorgan, Kentucky, Kong, Kuerbitz, laid, leasehold, lie, Lufthansa, Lutz, meaningful, mechanical, Mississippi, Nashville, NDA, NHSN, observed, optimal, oriented, originating, personam, Physiotherapy, prohibiting, proportionally, purified, Reciprocally, reclassification, recommenced, refinanced, repealed, retail, revaluation, Roche, Ronald, room, Rx, SASU, Schilling, securitization, selectively, semiannually, sentence, shock, shortening, sleep, soluble, specification, standardize, Stiefenhofer, Stiftung, Summit, Suntrust, supplying, swing, syndication, Tennessee, UFJ, undervalued, Unicredit, VA, ventilation, venue, visit, VU, web
Financial reports
Current reports
6-K
2022 Q2
Current report (foreign)
2 Aug 22
6-K
Fresenius Medical Care publishes financial results for the second quarter and first half of 2022 in line with preliminary results
2 Aug 22
6-K
Current report (foreign)
28 Jul 22
6-K
Current report (foreign)
17 May 22
6-K
Current report (foreign)
12 May 22
6-K
2022 Q1
Current report (foreign)
4 May 22
6-K
Fresenius Medical Care reports first quarter results in line with its expectations despite significant headwinds
4 May 22
6-K
Current report (foreign)
4 May 22
6-K
Invitation to the Annual General Meeting
30 Mar 22
6-K
Current report (foreign)
22 Mar 22
Registration and prospectus
F-6 POS
Automatic registration for ADRs (post-effective amendment, foreign)
18 Apr 18
25-NSE
Exchange delisting
30 Jun 13
S-8
Registration of securities for employees
30 Jun 13
424B3
Prospectus supplement
15 May 13
424B3
Prospectus supplement
15 May 13
424B3
Prospectus supplement
24 Jan 08
424B3
Prospectus supplement
26 Dec 07
F-4
Registration of securities (foreign)
2 Dec 07
424B3
Prospectus supplement
17 Jun 07
424B3
Prospectus supplement
17 Jun 07
Proxies
No filings
Other
SD
Conflict minerals disclosure
31 May 22
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
22 Feb 22
SD
Conflict minerals disclosure
28 May 21
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
23 Feb 21
SD
Conflict minerals disclosure
29 May 20
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
20 Feb 20
SD
Conflict minerals disclosure
31 May 19
IRAN
Disclosure regarding Iran Threat Reduction and Syria Human Rights Act
20 Feb 19
UPLOAD
Letter from SEC
19 Aug 18
CORRESP
Correspondence with SEC
14 Aug 18
Ownership
11-K
Annual report of employee stock purchases
29 Jun 22
11-K
Annual report of employee stock purchases
28 Jun 21
11-K
Annual report of employee stock purchases
26 Jun 20
11-K
Annual report of employee stock purchases
27 Jun 19
SC 13G/A
Beneficial ownership report (amended)
7 Jun 19
SC 13G/A
Beneficial ownership report (amended)
4 Feb 19
11-K
Annual report of employee stock purchases
29 Jun 18
SC 13G
Beneficial ownership report
7 Feb 18
11-K
Annual report of employee stock purchases
27 Jun 17
SC 13G/A
Beneficial ownership report (amended)
8 Nov 16
Reddit threads
Anyone else disappointed in this sub?
1 Aug 22
Most Anticipated Earnings Releases for the week beginning August 1st, 2022
30 Jul 22
DCAing when a stock is up
29 Jul 22
Daily Discussion Thread - July 29th, 2022
29 Jul 22
Daily Plays July 29, 2022
29 Jul 22
Daily Discussion Thread - July 28th, 2022
28 Jul 22
Daily Discussion Thread - July 27th, 2022
27 Jul 22
Daily Discussion - Tuesday July 19 2022
19 Jul 22
Investing $2,000,000 Rate my Potential Portfolio
9 Jul 22
Weekend Discussion - Weekend of July 09 2022
9 Jul 22